More news from Proactive Investors:
Polo Resources call for EGM at Extract Resources to appoint Stephen Dattels to board
Tuesday, May 26, 2009
Polo Resources call for EGM at Extract Resources to appoint Stephen Dattels to board
The plot thickens at Extract Resources (ASX & TSX: EXT). Yesterday Extract Resources requested a suspension in trading on the ASX, citing a dispute with its largest shareholder, Kalahari Minerals (AIM: KAH). Kalahari Minerals holds approximately 39.6% of Extract Resources.
This morning, Polo Resources (AIM: PRL), which holds approximately 9.08% of Extract Resources, said it was in the process of requisitioning an EGM of Extract Resources to appoint Stephen Dattels as a director of Extract. Stephen Dattels is Chairman of Polo Resources and Co-Chairman of Emerging Metals (AIM: EML) which holds a 9.84% stake in Kalahari Minerals. Polo Resources also confirmed that Mr Dattels has a beneficial interest in 0.92 % of Extract Resources.
Mr Dattels is also a director of Berkeley Resources which is a developer of Uranium resources in Spain.
“Polo is committed to seeing the development of the Rossing South Deposit owned by Extract as a stand alone operation,” commented Mr Dattels. “Work undertaken by Polo's technical advisor on a conceptual plan for the Rossing South Deposit, based on publicly available information, indicates that production is feasible as early as Q4 2011. This may be achievable as a 100% heap leaching operation, depending on the scheduling and results of feasibility work being undertaken by Extract.”
There are several other significant stakeholders in both Extract Resources and Kalahari Minerals. Rio Tinto (LSE: RIO) holds a 15.8% stake in Kalahari Minerals and a 15.6% stake in Extract. Niger Uranium (AIM: URU) holds a 15.5% stake in Kalahari Minerals.
- Forums
- ASX - By Stock
- EXT
- battle for rossing south uranium control
EXT
excite technology services ltd
Add to My Watchlist
11.1%
!
1.0¢

battle for rossing south uranium control, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $20.72M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.8¢ | $31.15K | 3.390M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1600000 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 1109800 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1600000 | 0.009 |
6 | 1884688 | 0.008 |
6 | 5198700 | 0.007 |
4 | 2850000 | 0.006 |
2 | 1280000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 627812 | 2 |
0.011 | 4227645 | 5 |
0.012 | 1982124 | 5 |
0.013 | 53000 | 1 |
0.014 | 1000000 | 1 |
Last trade - 15.23pm 27/06/2025 (20 minute delay) ? |
Featured News
EXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online